- Home
- GCI vs NPCE Comparison
GCI vs NPCE Comparison
Compare GCI & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GCI
- NPCE
- Stock Information
- Founded
- GCI 1997
- NPCE 1997
- Country
- GCI United States
- NPCE United States
- Employees
- GCI N/A
- NPCE N/A
- Industry
- GCI Newspapers/Magazines
- NPCE Medical Specialities
- Sector
- GCI Consumer Discretionary
- NPCE Health Care
- Exchange
- GCI Nasdaq
- NPCE Nasdaq
- Market Cap
- GCI 509.6M
- NPCE 424.1M
- IPO Year
- GCI N/A
- NPCE 2021
- Fundamental
- Price
- GCI $3.85
- NPCE $9.96
- Analyst Decision
- GCI Buy
- NPCE Buy
- Analyst Count
- GCI 3
- NPCE 7
- Target Price
- GCI $5.70
- NPCE $15.14
- AVG Volume (30 Days)
- GCI 1.6M
- NPCE 400.4K
- Earning Date
- GCI 07-31-2025
- NPCE 08-12-2025
- Dividend Yield
- GCI N/A
- NPCE N/A
- EPS Growth
- GCI N/A
- NPCE N/A
- EPS
- GCI 0.36
- NPCE N/A
- Revenue
- GCI $2,445,127,000.00
- NPCE $84,306,000.00
- Revenue This Year
- GCI N/A
- NPCE $21.00
- Revenue Next Year
- GCI N/A
- NPCE $11.81
- P/E Ratio
- GCI $10.38
- NPCE N/A
- Revenue Growth
- GCI N/A
- NPCE 22.05
- 52 Week Low
- GCI $2.55
- NPCE $5.45
- 52 Week High
- GCI $5.93
- NPCE $18.98
- Technical
- Relative Strength Index (RSI)
- GCI 60.10
- NPCE 39.51
- Support Level
- GCI $3.57
- NPCE $10.05
- Resistance Level
- GCI $3.84
- NPCE $10.64
- Average True Range (ATR)
- GCI 0.15
- NPCE 0.61
- MACD
- GCI 0.03
- NPCE 0.04
- Stochastic Oscillator
- GCI 84.78
- NPCE 40.06
About GCI Gannett Co. Inc.
Gannett Co Inc is a digital newspaper company providing local media and marketing solutions in the U.S. The group operates in three segments, Domestic Gannett Media, Newsquest, and Digital Marketing Solutions. The majority of revenue is from the Domestic Gannett Media segment. The company's brands include USA TODAY and more than 250 daily newspapers as well as digital marketing services companies, including ReachLocal, WordStream, and others. The company produces more than 350 annual events, such as themed expos. The company also operates in the U.K. through the U.K. media company Newsquest, providing more than 150 local media brands.
About NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.